Legal finance and life sciences: Unlocking IP potential in Europe’s pharma, biotech and medical devices sector
- Patent & IP
Summary
Innovation in life sciences is vital to advancing global healthcare, but it requires immense investment — of ideas, time, and capital. From navigating Europe’s complex IP frameworks to facing high-stakes R&D cycles, life sciences firms must strategically manage and monetize their intellectual property to sustain innovation, and are increasingly using legal finance to do so.
Across Europe, the life sciences industry plays a pivotal role in driving economic growth, enhancing global health outcomes and maintaining the region’s position as a hub of scientific excellence. But the industry operates in a high-risk, high-reward environment…
Provide your information below to view this page.
